RxDoctor Payments Data

Brooke Skinner, APRN

Family · Searcy, ARNPI 1295324481

Payments from drug & device makers

$1,105in general payments, 2019–2025

Across 55 payments — averaging $20.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$168
  • Lexicon Pharmaceuticals, Inc.$110
  • Pfizer$107
  • Boston Scientific$100
  • Agiliti Health, Inc.$79
  • Baxter Healthcare$72
  • plus $470 from 16 others

What the payments were for

  • Food & beverage$1,105100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,105 in reported general payments places this provider in the 70th percentile of 2,103 family providers in Arkansas.

See all family providers in Arkansas

Medicare billing

Part B allowed, 2024
$36,456
Medicare patients
477
Services billed
716

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban219$154,722
EntrestoSacubitril/Valsartan86$61,709
XareltoRivaroxaban64$52,544
FarxigaDapagliflozin Propanediol27$15,110
BrilintaTicagrelor17$11,188
JardianceEmpagliflozin12$8,885
Repatha SureclickEvolocumab12$6,665
Ranolazine ErRanolazine73$5,463
Sildenafil Citrate30$4,856
Metoprolol Succinate284$3,069
Nifedipine ErNifedipine142$1,832
Losartan Potassium229$1,700
Carvedilol336$1,503
Atorvastatin Calcium190$1,446
ClopidogrelClopidogrel Bisulfate185$1,288

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$107$154,722219 claims
NovartisEntresto$168$61,70986 claims
Johnson & JohnsonXarelto$35$52,54464 claims
AstraZenecaFarxiga, Brilinta$27$26,29844 claims
Boehringer IngelheimJardiance$15$8,88512 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,103 family providers in Arkansas.

Other family in Searcy

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →